IWP
IONS icon

Icon Wealth Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Icon Wealth Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$124K Sell
2,724
-13
-0.5% -$536 0.01% 349
2023
Q2 		$112K Sell
2,737
-336
-11% -$12.9K 0.01% 388
2023
Q1 		$110K Buy
+3,073
New +$115K 0.01% 394
2021
Q3 		– Sell
-5,917
Closed -$236K – 350
2021
Q2 		$236K Buy
5,917
+246
+4% +$9.63K 0.03% 326
2021
Q1 		$255K Buy
5,671
+273
+5% +$15.2K 0.03% 289
2020
Q4 		$305K Buy
5,398
+648
+14% +$32.3K 0.05% 226
2020
Q3 		$225K Buy
4,750
+342
+8% +$19K 0.04% 235
2020
Q2 		$260K Sell
4,408
-340
-7% -$18.9K 0.06% 208
2020
Q1 		$224K Sell
4,748
-99
-2% -$5.52K 0.09% 132
2019
Q4 		$293K Buy
4,847
+909
+23% +$54.2K 0.09% 124
2019
Q3 		$236K Buy
3,938
+139
+4% +$9.06K 0.08% 133
2019
Q2 		$244K Buy
3,799
+945
+33% +$66.8K 0.09% 128
2019
Q1 		$232K Sell
2,854
-539
-16% -$34.8K 0.09% 135
2018
Q4 		$183K Sell
3,393
-120
-3% -$6.12K 0.09% 146
2018
Q3 		$181K Sell
3,513
-258
-7% -$12.1K 0.08% 182
2018
Q2 		$157K Buy
3,771
+133
+4% +$5.9K 0.07% 182
2018
Q1 		$160K Buy
3,638
+15
+0.4% +$762 0.09% 187
2017
Q4 		$182K Buy
+3,623
New +$199K 0.09% 184

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Icon Wealth Partners's IONS Position: Q3 2023 in Review

Icon Wealth Partners reduced its Ionis Pharmaceuticals (IONS) stake by 0.47% in Q3 2023, selling an estimated $536 and leaving 2,724 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #349.

Icon Wealth Partners first reported a position in IONS in Q4 2017 and has held it in 18 quarters since. The position peaked at $305K in Q4 2020. 310 funds tracked by Wall St. Rank hold IONS as of Q3 2023.

  • Icon Wealth Partners held 2,724 shares of Ionis Pharmaceuticals worth $124K as of Q3 2023.
  • Icon Wealth Partners sold 13 Ionis Pharmaceuticals shares in Q3 2023, an estimated $536.
  • Ionis Pharmaceuticals made up 0.01% of Icon Wealth Partners's portfolio in Q3 2023, its #349 holding.
  • Icon Wealth Partners first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 18 quarters since.
  • Icon Wealth Partners's Ionis Pharmaceuticals position peaked at $305K in Q4 2020.
  • 310 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.